







































HIF = hypoxia inducible factor; MAPK = mitogen-activated protein kinase; MMP = matrix metalloproteinase; NADPH = nicotinamide adenine di-
nucleotide phosphate, reduced form; NOS = nitric oxide synthase; ROS = reactive oxygen species; VEGF = vascular endothelial growth factor.
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Introduction
Oxygen radicals are continuously generated within mam-
malian cells, this being a consequence of the use of
oxygen in aerobic respiration. Superoxide is generated
within the mitochondria and is sequentially reduced to
hydrogen peroxide and hydroxyl radicals. These species
damage DNA, producing the mutations that initiate
tumours and sustain progression [1]. Epidemiological
studies suggest that a diet that is rich in antioxidants may
help to prevent the development of breast carcinoma; this
evidence contributed to recent UK Government advice
that individuals should consume at least five portions of
fruit or vegetables each day. The UK Department of Health
has now translated this recommendation into initiatives
such as the National School Fruit Scheme and the Five-a-
day Community Projects (www.doh.gov.uk). The role of
ROS in breast carcinoma may not be limited to early muta-
genic events, however. Carcinoma cells are frequently
under persistent oxidative stress. Human tumour cell lines
in vitro produce ROS at a far greater rate than do non-
transformed cell lines [2], and markers of constitutive
oxidative stress have been detected in samples from in
vivo  breast carcinomas [3,4]. 8-Hydroxy-2′-deoxyguano-
sine, one of the major oxidatively modified DNA base prod-
ucts, is almost 10 times more prevalent in invasive ductal
breast carcinoma cells than in normal control samples
from the same patient [3]. It appears unlikely that such a
high level of oxidatively modified DNA is exclusively due to
the mutagens that initiated the tumour. Persistent oxidative
stress within carcinoma cells may instead be responsible
for the accumulation of 8-hydroxy-2′-deoxyguanosine. 
Causes of carcinoma cell oxidative stress
Alterations to metabolic pathways in tumour cells
Oxygen radicals are not only generated in the mitochon-
dria. Neutrophils and macrophages produce ROS via a
plasma membrane bound nicotinamide adenine dinu-
cleotide phosphate, reduced form (NADPH)-oxidase. The
radicals are generated for cell killing and bactericidal activ-
ities. The NADPH-oxidase is not exclusive to these cells,
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however. A panel of human tumour cell lines were shown
to produce large quantities of hydrogen peroxide in vitro
[2]. The hydrogen peroxide production was prevented by
diphenyleneiodonium, which is an inhibitor of the flavopro-
tein component of the NADPH-oxidase. Tumour cells may
overproduce ROS because the NADPH-oxidase is regu-
lated by the GTPase Rac1, which is itself downstream of
the proto-oncogene Ras [5].
Carcinoma cell oxidative stress can also be induced by
thymidine phosphorylase, an enzyme that is overexpressed
in the majority of breast carcinomas. Thymidine phosphory-
lase catabolizes thymidine to thymine and 2-deoxy-D-
ribose-1-phosphate; the latter is a very powerful reducing
sugar that rapidly glycates proteins, generating oxygen rad-
icals within the carcinoma cell. Thymidine phosphorylase
activity has been shown to induce carcinoma cell oxidative
stress in vitro [6]. The frequent upregulation of thymidine
phosphorylase in human breast tumours suggests that this
may be an important cause of oxidative stress in breast
cancer. Oxidative stress within breast carcinoma may also
be caused by a breast specific mechanism, namely the
metabolism of oestrogenic hormones by lactoperoxidase.
Lactoperoxidase, an enzyme that is produced within the
mammary gland, catalyzes the one-electron oxidation of
17β-oestradiol to a reactive phenoxyl radical [7].
The above metabolic changes will elicit carcinoma cell
oxidative stress both in vitro and in vivo. We now consider
further mechanisms by which tumour oxidative stress may
arise. These, however, are dependent on the in vivo
setting of the cancer.
An inadequate tumour vascular network
A breast tumour rapidly outgrows its blood supply, leading
to glucose deprivation and hypoxia. Glucose deprivation
rapidly induces cellular oxidative stress within the MCF-7
breast carcinoma cell line, although it does not cause
oxidative stress in nontransformed cell lines [8,9]. This
may be because glucose deprivation depletes intracellular
pyruvate within the breast carcinoma cell, preventing the
decomposition of endogenous oxygen radicals [8].
Breast carcinomas usually support their growth by stimu-
lating blood vessel development (angiogenesis). Blood
flow within these new vessels is often chaotic, causing
periods of hypoxia followed by reperfusion. Reperfusion
after myocardial infarction or cerebral ischaemia is known
to cause the generation of ROS. Oxygen radical produc-
tion during reperfusion may therefore be a cause of oxida-
tive stress within breast carcinomas.
Macrophage infiltration of the tumour
Breast tumours are frequently infiltrated by large numbers
of macrophages. These may contribute to carcinoma cell
oxidative stress, as tumour-associated macrophages have
been shown to deliver a sublethal oxidative stress to
murine mammary tumour cells [10]. This may be due to
oxygen radical production by the macrophages. In addi-
tion, tumour necrosis factor-α is secreted by tumour-
associated macrophages, and is known to induce cellular
oxidative stress [11].
Therapeutic interventions
Some anticancer therapies may add to the oxidative stress
within breast carcinomas. The chemotherapeutic agents
doxorubicin, mitomycin C, etoposide and cisplatin are
superoxide generating agents [12]. Radiotherapy and pho-
todynamic therapy generate oxygen radicals within the
carcinoma cell. The antioestrogen tamoxifen, increasingly
used alongside other breast cancer therapies, has also
been shown to induce oxidative stress within carcinoma
cells in vitro [13].
Consequences of carcinoma cell oxidative
stress
Increased mutation rate and accelerated tumour
progression
As previously noted, oxygen radicals are powerful DNA
damaging agents. ROS cause strand breaks, alterations in
guanine and thymine bases, and sister chromatid
exchanges [1]. This may inactivate additional tumour sup-
pressor genes within tumour cells, or further increase
expression of proto-oncogenes. Genetic instability due to
persistent carcinoma cell oxidative stress will therefore
increase the malignant potential of the tumour [2].
Activation of growth-promoting signalling pathways
Sublethal oxidative stress promotes cell proliferation in
vitro, with both superoxide and hydrogen peroxide stimulat-
ing growth [14]. Proliferation in response to hydrogen per-
oxide may be due to the activation of mitogen-activated
protein kinases (MAPKs). HeLa cells treated with hydrogen
peroxide undergo a sustained activation of all three MAPK
pathways [15]: extracellular signal related protein kinase;
c-Jun amino-terminal kinase/stress-activated protein kinase;
and p38. Hyperphosphorylation of c-Jun by oxidative stress
activates activator protein-1 in MCF-7 breast carcinoma
cells, a response that stimulates proliferation [16], and
multidrug-resistant human breast carcinoma cells rapidly
activate extracellular signal related protein kinase-2 when
stressed by glucose deprivation [9]. In addition, ROS may
trigger mitosis via MAPK independent mechanisms. Onco-
genic Ras causes ROS production by activating Rac1 and
the NADPH-oxidase. In Ras-transformed human fibroblasts,
ROS drive cell cycle progression without the activation of
MAPK pathways [17].
Adaptation to oxidative stress, resulting in increased
resistance to therapy
Severe oxidative stress leads to apoptosis. Conversely,







































resistance to apoptosis. The induction of programmed cell
death by ROS is dependent on p53 in both mouse and
human cell lines [18]. Constitutive oxidative stress within
breast carcinoma cells may therefore accelerate the selec-
tion of p53 knockout tumour cell clones, which have an
apoptosis resistant phenotype. Persistent oxidative stress
may also cause adaptive responses within the tumour cell
that confer resistance to apoptosis. The antioxidant thiols
thioredoxin and metallothionein are rapidly upregulated in
response to oxidative stress [12,19], and the antioxidants
malondialdehyde, superoxide dismutase, glutathione per-
oxidase and catalase show increased expression or activ-
ity in breast tumour tissue as compared with normal
controls [4]. An upregulation of anti-ROS defences in
cancer cells may explain why tumour cell lines in vitro are
extremely resistant to cytolysis by hydrogen peroxide [20].
In addition, antiapoptotic Akt (protein kinase B) is acti-
vated by hydrogen peroxide [21]. 
An antiapoptotic response to chronic oxidative stress may
have severe implications for anticancer therapy. As outlined
above, radiotherapy, photodynamic therapy and many
chemotherapies generate oxygen radicals. Their antitumour
activity is to a degree dependent on the induction of
tumour cell apoptosis in response to oxidative stress and
oxygen radical induced DNA damage [12]. Persistent
oxidative stress within carcinoma cells may therefore cause
resistance to therapy. Oxygen radicals might also increase
drug resistance by increasing carcinoma cell expression of
P-glycoprotein, the multidrug-resistance efflux pump [22].
Increased blood supply to tumour cells
Oxygen radicals increase tumour cell production of the
angiogenic factors IL-8 and vascular endothelial growth
factor (VEGF) [6]. Tumour cell oxidative stress also pro-
motes secretion of the matrix metalloproteinase-1
(MMP-1), a collagenase that aids vessel growth within the
tumour microenvironment [6]. Oxidative stress can there-
fore cause angiogenesis within breast carcinoma. Hypoxia
and oxidative stress may be found together within the
tumour, and VEGF production within oxidatively stressed
breast carcinomas may be augmented by synergy
between oxygen radicals and tumour hypoxia. Levels of
the hypoxia inducible factor-1 (HIF-1) may be increased by
oxygen radicals [23,24], implying that oxidatively stressed
carcinoma cells might show increased HIF-1 induction
during hypoxia and therefore produce more VEGF (Fig. 1).
Oxidative stress may also increase the blood supply to
breast carcinoma by triggering vasodilatation. Hydrogen
peroxide induces inducible nitric oxide synthase (NOS) in
cytokine stimulated rat pleural mesothelial cells [25],
raising the possibility that oxidatively stressed breast
tumour cells might show increased expression of inducible
NOS. The nitric oxide produced would activate cGMP
within nearby smooth muscle cells, leading to vasodilata-
tion. Vasodilatation could also be triggered by carbon
monoxide, because oxidative stress powerfully induces
heme oxygenase-1 [6], which degrades heme to biliverdin
and carbon monoxide. Carbon monoxide, like nitric oxide,
activates cGMP.
Increased risk of metastasis
Blood vessel growth within the breast tumour microenvi-
ronment increases the risk of blood-borne metastasis.
Angiogenesis may also promote lymphatic dissemination,
a common occurrence in breast carcinoma, by elevating
tumour interstitial pressure. These are not the only mecha-
nisms by which oxidative stress can aid tumour spread,
however. Oxygen radicals may also augment tumour cell
migration, increasing the risk of invasion and metastasis.
The p38 MAPK is activated by oxidative stress [15], and
the phosphorylation of heat shock protein-27 by p38
MAPK has been shown to induce changes in actin dynam-
ics [26]. Phosphorylated heat shock protein-27 promotes
the migration of MDA-MB-231 breast cancer cells on
laminin-5 in vitro [27]. As noted earlier, Rac1 can activate
the NADPH-oxidase in tumour cells, causing superoxide
production. ROS have been shown to mediate the role of
Rac1 in actin cytoskeleton reorganization [28].
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Figure 1
Oxygen radicals and oxygen insufficiency (hypoxia) co-operatively
promote tumour angiogenesis. Breast carcinomas frequently outgrow
their blood supply, leading to oxygen insufficiency (hypoxia) within the
tumour. Hypoxia causes necrosis, and DNA is subsequently degraded
to its constituent bases. Any thymidine released is catabolized by
thymidine phosphorylase, an enzyme that is frequently overexpressed
within breast carcinomas. Thymidine phosphorylase activity causes
oxygen radical production, as described by Brown et al [6].
Reoxygenation of the tumour after hypoxia will drive additional oxygen
radical formation. Breast tumours are also oxidatively stressed by
nonhypoxic mechanisms, such as glucose deprivation, metabolic
alterations and macrophage infiltration. Hypoxia causes the
accumulation of the transcription factor HIF-1, which promotes
transcription of the angiogenic factor VEGF. HIF-1 levels may also be
increased by oxygen radicals. In addition, oxygen radicals increase
production of the angiogenic factors VEGF and IL-8 via HIF-1-
independent mechanisms.Oxidative stress within breast tumours may also facilitate
invasion and metastasis by activating MMPs and inhibiting
antiproteases. MMP-2 is a gelatinase that is believed to
play a major role in breast cancer invasion and metastasis.
High levels of MMP-2 correlate with poor prognosis in
breast cancer patients [29] and active MMP-2 is detected
more frequently in malignant than in benign breast
tumours. ROS have been shown to activate MMP-2,
possibly by the reaction of oxygen radicals with thiol
groups within MMP-2 [30]. Protease inhibitors, such as
α1-proteinase inhibitor and plasminogen activator inhibitor,
may be inactivated by oxidation of methionine residues at
their active sites [31]. This facilitates the activity of various
proteases, increasing invasion and the likelihood of metas-
tasis. For example, plasminogen activator is believed to
play a role in metastasis [2].
Murine mammary carcinoma cells that are exposed to sub-
lethal oxidative stress exhibit decreased attachment to
immobilized laminin and fibronectin [10]. Reduced tumour
cell adhesion to basement membrane components
increases the probability that the cells will detach and enter
the blood vessels or lymphatic system. In addition, treat-
ment of these cells with hydrogen peroxide, before intra-
venous injection into mice, enhanced lung metastasis
formation. This implies that oxidative stress may aid the
seeding of metastatic tumour cells [10]. Finally, ROS within
the tumour microenvironment may promote metastasis by
increasing vascular permeability, either by direct damage to
endothelial cells or by the upregulation of inducible NOS
and heme oxygenase-1 previously proposed.
Conclusion
Carcinoma cells synthesize ROS at an elevated rate in
vitro, and many tumours in vivo appear to be under persis-
tent oxidative stress. The present review outlines potential
causes of carcinoma cell oxidative stress in vitro and in
vivo, and summarizes mechanisms by which oxygen radi-
cals may affect the outcome of breast cancer. Future
experiments will reveal the extent to which oxidative stress
influences the prognosis of breast carcinoma. If oxygen
radicals do lead to a poorer prognosis, then antioxidants
may be of therapeutic value. This is an exciting possibility,
because antioxidants are drugs of low toxicity. Evidence
from other tumour types suggests that antioxidants may
indeed be of use against breast cancer. For example,
transfection of human melanoma cells with cDNA encod-
ing the antioxidant enzyme manganese superoxide dismu-
tase suppressed their malignant phenotype. The cells lost
their ability to form colonies on soft agar, and no longer
formed tumours in nude mice [32].
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